533 related articles for article (PubMed ID: 12791824)
41. Dynamic distribution and dosimetric evaluation of human non-specific immunoglobulin G labelled with 111In or 99Tcm.
Buijs WC; Oyen WJ; Dams ET; Boerman OC; Siegel JA; Claessens RA; van der Meer JW; Corstens FH
Nucl Med Commun; 1998 Aug; 19(8):743-51. PubMed ID: 9751928
[TBL] [Abstract][Full Text] [Related]
42. Biodistribution and dosimetry of technetium-99m-hydrazino nicotinamide IgG: comparison with indium-111-DTPA-IgG.
Callahan RJ; Barrow SA; Abrams MJ; Rubin RH; Fischman AJ
J Nucl Med; 1996 May; 37(5):843-6. PubMed ID: 8965158
[TBL] [Abstract][Full Text] [Related]
43. Targeted imaging of gastrin-releasing peptide receptors with 99mTc-EDDA/HYNIC-[Lys3]-bombesin: biokinetics and dosimetry in women.
Santos-Cuevas CL; Ferro-Flores G; Arteaga de Murphy C; Pichardo-Romero PA
Nucl Med Commun; 2008 Aug; 29(8):741-7. PubMed ID: 18753829
[TBL] [Abstract][Full Text] [Related]
44. A preliminary study of imaging paclitaxel-induced tumor apoptosis with (99)Tc(m)-His10-Annexin V.
Zheng YM; Wang F; Fang W; Hua ZC; Wang ZZ; Meng QL; Yan J
Chin Med J (Engl); 2013; 126(15):2928-33. PubMed ID: 23924470
[TBL] [Abstract][Full Text] [Related]
45. PET-based radiation dosimetry in man of 18F-fluorodihydrotestosterone, a new radiotracer for imaging prostate cancer.
Zanzonico PB; Finn R; Pentlow KS; Erdi Y; Beattie B; Akhurst T; Squire O; Morris M; Scher H; McCarthy T; Welch M; Larson SM; Humm JL
J Nucl Med; 2004 Nov; 45(11):1966-71. PubMed ID: 15534070
[TBL] [Abstract][Full Text] [Related]
46. Biodistribution and Internal Radiation Dosimetry of
Song YS; Kim JH; Lee BC; Jung JH; Park HS; Kim SE
Cancer Biother Radiopharm; 2018 Nov; 33(9):396-402. PubMed ID: 30133309
[TBL] [Abstract][Full Text] [Related]
47. Intracellular metabolic fate of radioactivity after injection of technetium-99m-labeled hydrazino nicotinamide derivatized proteins.
Ono M; Arano Y; Uehara T; Fujioka Y; Ogawa K; Namba S; Mukai T; Nakayama M; Saji H
Bioconjug Chem; 1999; 10(3):386-94. PubMed ID: 10346868
[TBL] [Abstract][Full Text] [Related]
48. Mapping of treatment-induced apoptosis in normal structures: 99mTc-Hynic-rh-annexin V SPECT and CT image fusion.
Kartachova MS; Valdés Olmos RA; Haas RL; Hoebers FJ; van den Brekel MW; van Zandwijk N; Herk Mv; Verheij M
Eur J Nucl Med Mol Imaging; 2006 Aug; 33(8):893-9. PubMed ID: 16586080
[TBL] [Abstract][Full Text] [Related]
49. Biodistribution and radiation dosimetry of the serotonin transporter ligand 11C-DASB determined from human whole-body PET.
Lu JQ; Ichise M; Liow JS; Ghose S; Vines D; Innis RB
J Nucl Med; 2004 Sep; 45(9):1555-9. PubMed ID: 15347724
[TBL] [Abstract][Full Text] [Related]
50. Enhanced apoptotic reaction correlates with suppressed tumor glucose utilization after cytotoxic chemotherapy: use of 99mTc-Annexin V, 18F-FDG, and histologic evaluation.
Takei T; Kuge Y; Zhao S; Sato M; Strauss HW; Blankenberg FG; Tait JF; Tamaki N
J Nucl Med; 2005 May; 46(5):794-9. PubMed ID: 15872353
[TBL] [Abstract][Full Text] [Related]
51. Influence of chemotherapy on the biodistribution of [99mTc]hydrazinonicotinamide annexin V in cancer patients.
Rottey S; Van den Bossche B; Slegers G; Van Belle S; van de Wiele C
Q J Nucl Med Mol Imaging; 2009 Apr; 53(2):127-32. PubMed ID: 19039304
[TBL] [Abstract][Full Text] [Related]
52. 99mTc-Hynic-annexin V imaging to evaluate inflammation and apoptosis in rats with autoimmune myocarditis.
Tokita N; Hasegawa S; Maruyama K; Izumi T; Blankenberg FG; Tait JF; Strauss HW; Nishimura T
Eur J Nucl Med Mol Imaging; 2003 Feb; 30(2):232-8. PubMed ID: 12552341
[TBL] [Abstract][Full Text] [Related]
53. Biodistribution and radiation dosimetry of 11C-WAY100,635 in humans.
Parsey RV; Belanger MJ; Sullivan GM; Simpson NR; Stabin MG; Van Heertum R; Mann JJ
J Nucl Med; 2005 Apr; 46(4):614-9. PubMed ID: 15809484
[TBL] [Abstract][Full Text] [Related]
54. Whole-body biodistribution, radiation dosimetry estimates for the PET norepinephrine transporter probe (S,S)-[18F]FMeNER-D2 in non-human primates.
Seneca N; Andree B; Sjoholm N; Schou M; Pauli S; Mozley PD; Stubbs JB; Liow JS; Sovago J; Gulyás B; Innis R; Halldin C
Nucl Med Commun; 2005 Aug; 26(8):695-700. PubMed ID: 16000987
[TBL] [Abstract][Full Text] [Related]
55. Phase I clinical study with different doses of
Sun Y; Chen Z; Liu C; Tang J; Wang Y; Zhang G; Liu X
Ann Nucl Med; 2020 Mar; 34(3):212-219. PubMed ID: 32030559
[TBL] [Abstract][Full Text] [Related]
56. 99mTc-labeled annexin V fragments: a potential SPECT radiopharmaceutical for imaging cell death.
Mukherjee A; Kothari K; Tóth G; Szemenyei E; Sarma HD; Környei J; Venkatesh M
Nucl Med Biol; 2006 Jul; 33(5):635-43. PubMed ID: 16843838
[TBL] [Abstract][Full Text] [Related]
57. Optimization of the preparation of 99mTc-labeled Hynic-derivatized Annexin V for human use.
Verbeke K; Kieffer D; Vanderheyden JL; Reutelingsperger C; Steinmetz N; Green A; Verbruggen A
Nucl Med Biol; 2003 Oct; 30(7):771-8. PubMed ID: 14499336
[TBL] [Abstract][Full Text] [Related]
58. Intravenous administration of 99mTc-HMPAO-labeled human mesenchymal stem cells after stroke: in vivo imaging and biodistribution.
Detante O; Moisan A; Dimastromatteo J; Richard MJ; Riou L; Grillon E; Barbier E; Desruet MD; De Fraipont F; Segebarth C; Jaillard A; Hommel M; Ghezzi C; Remy C
Cell Transplant; 2009; 18(12):1369-79. PubMed ID: 19849895
[TBL] [Abstract][Full Text] [Related]
59. Iodine-123-vascular endothelial growth factor-165 (123I-VEGF165). Biodistribution, safety and radiation dosimetry in patients with pancreatic carcinoma.
Li S; Peck-Radosavljevic M; Kienast O; Preitfellner J; Havlik E; Schima W; Traub-Weidinger T; Graf S; Beheshti M; Schmid M; Angelberger P; Dudczak R
Q J Nucl Med Mol Imaging; 2004 Sep; 48(3):198-206. PubMed ID: 15499293
[TBL] [Abstract][Full Text] [Related]
60. Pharmacokinetics and biodistribution of 99mTc N-MPO in healthy human volunteers.
Gao S; Zhao G; Wen Q; Bai L; Chen B; Ji T; Ji B; Ma Q
Clin Nucl Med; 2014 Jan; 39(1):e14-9. PubMed ID: 23917788
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
